Modi Y, Ogata S, Clements D,et al. Structure of the dengue virus envelope protein after membrane fusion.Nature.2004,427(6972):313-319
[4]
Kuhn RJ, Zhang W, Rossmann MG, et al. Structure of dengue virus: implications for flavivirus organization, maturation,and fusion. Cell.2002,108(5):717-725.
[5]
Gregory D, Gromowski,,Alan DT. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain Ⅲ(ED3)of dengue 2 virus.Virology,2007,366(2):349-360.
[6]
Mota J, Acosta M, Argotte R, et al. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein .Vaccine. 2005,23(26)：3469-3476.
[7]
Randolph VB, Winkler G, Stollar V. Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. Virology, 1990,174(20):450-458.
[8]
李敏,金侠 登革病毒疫苗研究现状与展望.生命的化学,2014,34（1）：29-38.
[9]
Wright PJ,Cauchi MR, Ng ML, Definition of the carboxy termini of the three glycoproteins specified by dengue virus type 2. Virology, 1989,171（1）:61-67.
[10]
Dejnirattisai W. Jumnainsong A, Qnsirisakul N, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science, 2010,328(5979):745-748.
[11]
Belramello M, Williams K, Simmons C, et al. The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell host microbe,2010.8(3):271-283.
[12]
Allison SL, Stadler K, Mandel CW, et al. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Vriol.1995, 69(9):5816-5820.
[13]
Raviprakash K, Porter KR, Kochel TJ, et al. Dengue virus type l DNA vaccine induces protective immune responses in rhesus macaques. J Gen Viro1, 2000, 81(7):1659-1667.
[14]
Kochel TJ, Raviprakash K, Hayes CG, et al. A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys. Vaccine.2000, 18(27):3166-3173.
[15]
Raviprakash K, Kochel TJ, Ewing D, et al. Immunogenicity of dengue virus type .1 DNA vaccines expressing truncated and full length envelope protein.Vaccine.2000, 18(22):2416-2434.
[16]
Kochel T, Wu SJ, Raviprakash K et al. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine, 1997, 15(5):547-552.
[17]
Konishi E, Fujii A. Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine. Vaccine, 2002, 20(7):1058-1067.
[18]
Fonseca BA, Pincus S, Shope RE, et al. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine 1994, 12(3):279-285.
[19]
Osorio JE, Huang CY, Kinney RM, et al. Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever [J].Vaccine,2011,29(42):7251-7260.
[20]
Li XF, Deng YQ, Yang HQ, et al. A chimeric dengue virus vaccine using Japanese encephalitis vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice or nonhuman primates. J Virol,2013,87(24):13694-13705.
[21]
Brewoo J, Kinney R, Powell T, et al. Immunogenicity and efficacy of chimeric dengue vaccine(DENVax) formulation in interferon-deficient AG129 mice.Vaccine,2011,30(8):1513-1520.
[22]
Liu W Q, Jiang H N, Zhou J M, et al. Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties[J].Virus Genes,2010,40(1):53-59.
[23]
Timofee AV, Butenko VM, Stephenson JR. Genetic vaccination of mice with plamids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus. Virus Genes.2004,28(1):85-97.
[24]
Chalfie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression .Science, 1994, 263(5148):802-805.
[25]
Gerdes HH, Kaether C. Green fluorescent applications: in cell biology. FEBS Lett, 1996, 389(1):44-47.
[26]
Scalesa SJ, Pepperkok R , KreisTE .Visualization of ER-to-Golgi transport in living cells reveals a sequential mode of action for COPⅡand COPⅠ.Cell, 1997, 90(6):1137-1148.
